4//SEC Filing
Merten Jesse E 4
Accession 0001127602-25-004385
CIK 0000899051other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:29 PM ET
Size
29.1 KB
Accession
0001127602-25-004385
Insider Transaction Report
Form 4
Merten Jesse E
EVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-10−19,672→ 0 totalExercise: $124.26From: 2023-02-19Exp: 2030-02-19→ Common Stock (19,672 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-10−9,730→ 0 totalExercise: $105.08From: 2024-02-18Exp: 2031-02-18→ Common Stock (9,730 underlying) - Exercise/Conversion
Common Stock
2025-02-10$100.80/sh+700$70,560→ 18,815 total - Exercise/Conversion
Common Stock
2025-02-10$124.26/sh+19,672$2,444,443→ 38,487 total - Exercise/Conversion
Common Stock
2025-02-10$105.08/sh+9,730$1,022,428→ 48,217 total - Exercise/Conversion
Common Stock
2025-02-10$122.64/sh+10,000$1,226,400→ 58,217 total - Sale
Common Stock
2025-02-10$186.03/sh−27,315$5,081,314→ 30,902 total - Sale
Common Stock
2025-02-10$187.20/sh−8,592$1,608,382→ 22,310 total - Sale
Common Stock
2025-02-10$188.14/sh−2,654$499,315→ 19,656 total - Sale
Common Stock
2025-02-10$188.99/sh−1,541$291,234→ 18,115 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-10−700→ 0 totalExercise: $100.80From: 2021-01-04Exp: 2028-01-04→ Common Stock (700 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-10−10,000→ 12,879 totalExercise: $122.64Exp: 2032-02-17→ Common Stock (10,000 underlying)
Holdings
- 7,484(indirect: By 401(k))
Common Stock
Footnotes (5)
- [F1]Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $185.640 to $186.630. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F2]Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $186.670 to $187.610. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F3]Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $187.670 to $188.615. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F4]Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $188.830 to $189.740. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F5]Stock option award granted on February 17, 2022, for 22,879 shares of common stock vesting in three equal increments. The remaining increment will vest on February 17, 2025.
Issuer
ALLSTATE CORP
CIK 0000899051
Entity typeother
Related Parties
1- filerCIK 0001725539
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:29 PM ET
- Size
- 29.1 KB